Collaboration Will Target New Tools to Enhance Early Cancer Detection and Intervention AUSTIN, Texas & FRANKLIN LAKES, N.J.--Luminex Corporation (NASDAQ: LMNX), a worldwide leader in multiplexed solutions, and global medical technology company BD (NYSE: BDX), through its BD Diagnostics-TriPath platform, today announced the signing of a development and supply agreement. Under the terms of the [...]

X-ray fluorescence (XRF) spectroscopy has emerged as an optimal solution for the screening of toxic heavy metals regulated by the EU Directives RoHS (Restriction of Hazardous Substances) and WEEE (Waste Electronic and Electrical Equipment). To help customers who export goods to the EU meet increasingly complex environmental regulations, PANalytical delivers the advantage of 60 years [...]

GE Healthcare, a unit of General Electric Company (NYSE:GE), today announced it has acquired MicroCal LLC, a provider of innovative instruments for the study of molecular interactions in pharmaceutical, biomedical and life science research. The acquisition of MicroCal will allow GE Healthcare to expand its offering of technologies for the rapidly growing areas of protein [...]

Osmetech plc ('Osmetech') (LSE:OMH), the international molecular diagnostics business, today announced that it has signed an agreement with QIAGEN (Nasdaq: QGEN; Frankfurt Prime Standard: QIA) pursuant to which Osmetech will adapt a QIAplex-based respiratory viral test for use on Osmetech's recently launched eSensor XT-8 molecular diagnostics system. Under the terms of the agreement, QIAGEN will [...]

Applied Biosystems Inc. (NYSE:ABI) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its new 7500 Fast Dx Real-Time PCR Instrument for use with the new CDC Human Influenza Virus Real-time RT-PCR Detection and Characterization Panel (rRT-PCR Flu Panel) from the U.S. Centers for Disease Control and Prevention. [...]

BOSTON, Sept. 30 -- Riverside Partners, based in Boston, MA, is pleased to announce the sale of its portfolio company, MicroCal, to GE Healthcare, a unit of General Electric Company (NYSE: GE). MicroCal, based in Northampton, MA, develops and manufactures microcalorimeters that provide detailed information on the structure, function and binding properties of a wide [...]

454 Life Sciences, a Roche company, and GenomeQuest, Inc. announced a co-marketing agreement whereby GenomeQuest will offer its recently launched On-Demand Informatics Service to users of the 454 Genome Sequencer FLX System. GenomeQuest's high-throughput annotation and data management tools enable rapid characterization of all sequences generated by the Genome Sequencer FLX System. The combination of [...]

SUNNYVALE, Calif., Sept. 29 -- Cepheid (Nasdaq: CPHD) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert(TM) MRSA/SA Skin and Soft Tissue Infection (SSTI) test, which runs on the GeneXpert(R) System, for the rapid detection of Methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus (SA, typically Methicillin-sensitive) [...]

National Cancer Institute Selects CambridgeSoft to Support Chemical Biology Consortium CAMBRIDGE, Mass.--The National Cancer Institute has selected the ChemBioOffice Enterprise suite as the single solution Informatics platform to support a highly collaborative drug discovery partnership, the Chemical Biology Consortium. The ChemBioOffice Enterprise suite will allow members of the Consortium to manage and share vital scientific [...]

Industry’s Most Cited Gene Expression Content Now Available in More Flexible, Affordable and Easier-to-Use Array Plate Formats SANTA CLARA, Calif.--Affymetrix Inc. (NASDAQ:AFFX) today announces the GeneTitan™ System, the only complete platform to automate customer workflow from target preparation through array processing and data analysis, which maximizes data reproducibility, user productivity and throughput scalability. The first [...]